“Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis”. Farmeconomia. Health Economics and Therapeutic Pathways 19, no. 1 (November 30, 2018). Accessed December 28, 2025. https://journals.seedstm.com/index.php/FE/article/view/1385.